Henrietta Lacks' family sues Ultragenyx over use of immortal HeLa cell line, claiming unjust enrichment
11 Aug 2023
Gene TherapyPatent Infringement
The family of Henrietta Lacks has sued again over the use of her immortal cell line, this time going after Ultragenyx in Maryland District Court, alleging that its “competitive advantage” in gene therapy is the “theft” of Lacks’ cells.
The estate said in court documents filed Thursday that the company’s “ill-gotten gains” belong to the Lacks’ estate and that it wants the court to stop UltragenyxUltragenyx from using her cell line without the estate’s permission. Accusing Ultragenyx of unjust enrichment, the estate is also asking to be awarded the money the company has made from using the line.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.